This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (17)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stanley D. Handler, MD; Neil R. Hirsch, MD; Kenneth Haas, MD; Franklin Z. Davidson, MD

Arch Intern Med. 1975;135(6):871-872.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is well known that quinidine may cause extracardiac toxicity including effects on the gastrointestinal, hematopoietic, auditory, optic, and respiratory systems.¹ To our knowledge, only two cases of quinidine hepatotoxicity have been reported in the world's literature. A third case is now presented, proved by biopsy and confirmed by drug challenge.

PATIENT SUMMARY

A 72-year-old woman was admitted to Montefiore Hospital Medical Center for evaluation of abnormal liver function tests. Sixteen months previously, she had been treated for bigeminal heart rhythm with quinidine, 200 mg/six hours. Prior to therapy, blood chemical findings including serum glutamic oxaloacetic transaminase (SGOT) were within normal limits, but seven months later the SGOT level was 367 milli-International Units (mIU)/ml (normal, 10 to 50). Through the nine months before her admission, her SGOT levels ranged from 490 to 795 mIU/ml and were associated with anorexia and a 4.5-kg (10lb) weight loss. There were no symptoms . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Medicine and the Division of Gastroenterology, Montefiore Hospital Medical Center, Bronx, NY.

Footnotes
Received for publication July 6,1974; accepted Dec 3.

Reprint requests to 2830 Grand Concourse, Bronx, NY 10458 (Dr. Handler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?